Rituparna Das

Employment

• Emory University Scientist, Asc (AR)
  2018 - Present
• Yale University School of Medicine Post Doctoral Associate
  2012 - 2018

Education

• National Institute of Immunology Ph.D.
  2006 - 2012
• All India Institute of Medical Sciences Masters in Science
  2004 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Checkpoint Inhibition in Myeloma: Opportunities and Challenges
  Frontiers in immunology 2018 DOI: 10.3389/fimmu.2018.02204
  +Save
• Early b cell changes predict autoimmunity following combination immune checkpoint blockade
  Journal of Clinical Investigation 2018 DOI: 10.1172/JCI96798
  +Save
• Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice
  Nature Medicine 2016 DOI: 10.1038/nm.4202
  +Save
• Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: Impact of immune activation and cereblon targets
  Blood 2015 DOI: 10.1182/blood-2014-11-611426
  +Save
• Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo
  Journal of Immunology 2015 DOI: 10.4049/jimmunol.1401686
  +Save
• Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy
  Blood 2015 DOI: 10.1182/blood-2015-03-632919
  +Save
• Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer.
  2014
  +Save
• Peripheral residence of naïve CD4 T cells induces MHC class II-dependent alterations in phenotype and function
  BMC Biology 2014 DOI: 10.1186/s12915-014-0106-0
  +Save
• SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer
  OncoImmunology 2013 DOI: 10.4161/onci.25205
  +Save
• T cell ageing: Effects of age on development, survival & function
  Indian Journal of Medical Research 2013
  +Save